Status:
COMPLETED
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Type 2 Diabetes Mellitus
Carotid Atherosclerosis
Eligibility:
All Genders
30-80 years
Phase:
PHASE4
Brief Summary
To investigate the effect of cilostazol compared with aspirin on carotid atherosclerosis in patients with type 2 diabetes mellitus
Eligibility Criteria
Inclusion
- Age between 30 and 80 years
- Patients with type 2 diabetes on treatment (HbA1c 6.0-11.0%)
- Carotid plaque on 3D ultrasound
Exclusion
- Acute bleeding or bleeding tendency
- Diagnosed with heart failure
- Suggestive of ischemia on ECG
- Uncontrolled hypertension
- Recently diagnosed with peptic ulcer disease
- Taking other antiplatelet agents
- Hypersensitivity to salicylic acid
- Aspirin induced asthma
- Severe kidney, liver, heart disease
Key Trial Info
Start Date :
September 26 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03248401
Start Date
September 26 2016
End Date
December 31 2019
Last Update
April 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707